In this issue:
Adjuvant therapy timing in stage I–II resected pancreatic cancer
ctDNA: prognostic potential in CRC surveillance?
Using MRI to select “good prognosis” rectal cancer for primary surgery
Gemcitabine/nab-paclitaxel ± HCQ in advanced pancreatic cancer
Regorafenib dose-optimisation in mCRC
Postoperative CEA: a prognostic factor for survival in stage II colon cancer
Binimetinib + capecitabine in pretreated BTC
Older vs younger patients in surgical management of CRC
Individually tailor adjuvant chemotherapy in high-risk colon cancer
Please login below to download this issue (PDF)